Multiplex PCR assay underreports true bloodstream infections with coagulase-negative staphylococci in hematological patients with febrile neutropenia

Diagnostic Microbiology and Infectious Disease

Volumn 85, Issue 4, 2016, Pages 413-415

  Reers, Yvonne ^a   Idelevich, Evgeny A ^a   Pätkau, Hanna ^a   Sauerland, Maria Cristina ^b   Tafelski, Sascha ^c   Nachtigall, Irit ^c   Berdel, Wolfgang E ^a   Peters, Georg ^a   Silling, Gerda ^a   Becker, Karsten ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Bloodstream infections; Coagulase negative staphylococci; Cutoff; Febrile neutropenia; Multiplex PCR

Indexed keywords

GENTAMICIN; OXACILLIN; TEICOPLANIN; VANCOMYCIN; COAGULASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; BLOOD SAMPLING; BLOODSTREAM INFECTION; CANCER PATIENT; CENTRAL VENOUS CATHETER; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; FEBRILE NEUTROPENIA; FEVER; HEMATOLOGIC DISEASE; HUMAN; IMMUNOCOMPROMISED PATIENT; LEUKOCYTE COUNT; LEUKOPENIA; LUNG DISEASE; MAJOR CLINICAL STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SEPSIS; STEM CELL TRANSPLANTATION; ADULT; COMPLICATION; ENZYMOLOGY; EVALUATION STUDY; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOLECULAR DIAGNOSIS; PROCEDURES; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

ADULT; BACTERIOLOGICAL TECHNIQUES; COAGULASE; FEBRILE NEUTROPENIA; HEMATOLOGIC NEOPLASMS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MULTIPLEX POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEPSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

EID: 84975478019     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2016.04.024     Document Type: Article

References (24)

1. Becker, K., Heilmann, C., Peters, G., Coagulase-negative staphylococci. Clin Microbiol Rev 27 (2014), 870–926.
2. Beekmann, S.E., Diekema, D.J., Doern, G.V., Determining the clinical significance of coagulase-negative staphylococci isolated from blood cultures. Infect Control Hosp Epidemiol 26 (2005), 559–566.
3. Bucaneve, G., Micozzi, A., Menichetti, F., Martino, P., Dionisi, M.S., Martinelli, G., et al. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 353 (2005), 977–987.
4. Cherif, H., Kronvall, G., Bjorkholm, M., Kalin, M., Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis. Hematol J 4 (2003), 420–426.
5. de Naurois, J., Novitzky-Basso, I., Gill, M.J., Marti, F.M., Cullen, M.H., Roila, F., Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol 21:Suppl. 5 (2010), v252–v256.
6. Freifeld, A.G., Bow, E.J., Sepkowitz, K.A., Boeckh, M.J., Ito, J.I., Mullen, C.A., et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52 (2011), e56–e93.
7. Gaieski, D.F., Edwards, J.M., Kallan, M.J., Carr, B.G., Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med 41 (2013), 1167–1174.
8. Horan, T.C., Andrus, M., Dudeck, M.A., CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36 (2008), 309–332.
9. Idelevich, E.A., Silling, G., Niederbracht, Y., Penner, H., Sauerland, M.C., Tafelski, S., et al. Impact of multiplex PCR on antimicrobial treatment in febrile neutropenia: a randomized controlled study. Med Microbiol Immunol 204 (2015), 585–592.
10. Josefson, P., Stralin, K., Ohlin, A., Ennefors, T., Dragsten, B., Andersson, L., et al. Evaluation of a commercial multiplex PCR test (SeptiFast) in the etiological diagnosis of community-onset bloodstream infections. Eur J Clin Microbiol Infect Dis 30 (2011), 1127–1134.
11. Kaspar, U., Kriegeskorte, A., Schubert, T., Peters, G., Rudack, C., Pieper, D.H., et al. The culturome of the human nose habitats reveals individual bacterial fingerprint patterns. Environ Microbiol, 2015, 10.1111/1462-2920.12891.
12. Kumar, A., Roberts, D., Wood, K.E., Light, B., Parrillo, J.E., Sharma, S., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34 (2006), 1589–1596.
13. Lamoth, F., Jaton, K., Prod'hom, G., Senn, L., Bille, J., Calandra, T., et al. Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia. J Clin Microbiol 48 (2010), 3510–3516.
14. Lehmann, L.E., Hunfeld, K.P., Emrich, T., Haberhausen, G., Wissing, H., Hoeft, A., Stuber, F., A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples. Med Microbiol Immunol 197 (2008), 313–324.
15. Marra, A.R., Camargo, L.F., Pignatari, A.C., Sukiennik, T., Behar, P.R., Medeiros, E.A., et al. Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study. J Clin Microbiol 49 (2011), 1866–1871.
16. Maubon, D., Hamidfar-Roy, R., Courby, S., Vesin, A., Maurin, M., Pavese, P., et al. Therapeutic impact and diagnostic performance of multiplex PCR in patients with malignancies and suspected sepsis. J Infect 61 (2010), 335–342.
17. Pagano, L., Tacconelli, E., Tumbarello, M., Laurenti, L., Ortu-La, B.E., Antinori, A., et al. Bacteremia in patients with hematological malignancies. Analysis of risk factors, etiological agents and prognostic indicators. Haematologica 82 (1997), 415–419.
18. Paolucci, M., Stanzani, M., Melchionda, F., Tolomelli, G., Castellani, G., Landini, M.P., et al. Routine use of a real-time polymerase chain reaction method for detection of bloodstream infections in neutropaenic patients. Diagn Microbiol Infect Dis 75 (2013), 130–134.
19. Passerini, R., Ghezzi, T., Sandri, M., Radice, D., Biffi, R., Ten-year surveillance of nosocomial bloodstream infections: trends of aetiology and antimicrobial resistance in a comprehensive cancer centre. Ecancermedicalscience, 5, 2011, 191.
20. Penack, O., Buchheidt, D., Christopeit, M., von Lilienfeld-Toal, M., Massenkeil, G., Hentrich, M., et al. Management of sepsis in neutropenic patients: guidelines from the infectious diseases working party of the German Society of Hematology and Oncology. Ann Oncol 22 (2011), 1019–1029.
21. Grade. Package Insert 04623886001–06. Mannheim, Germany. 2011.
22. Tafelski, S., Nachtigall, I., Adam, T., Bereswill, S., Faust, J., Tamarkin, A., et al. Randomized controlled clinical trial evaluating multiplex polymerase chain reaction for pathogen identification and therapy adaptation in critical care patients with pulmonary or abdominal sepsis. J Int Med Res 43 (2015), 364–377.
23. Varani, S., Stanzani, M., Paolucci, M., Melchionda, F., Castellani, G., Nardi, L., et al. Diagnosis of bloodstream infections in immunocompromised patients by real-time PCR. J Infect 58 (2009), 346–351.
24. Williams, M.D., Braun, L.A., Cooper, L.M., Johnston, J., Weiss, R.V., Qualy, R.L., et al. Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Crit Care 8 (2004), R291–R298.